logo
‘My cancer was found because doctor did the lifetime risk assessment test': Olivia Munn says mammogram couldn't detect Stage 1 breast cancer

‘My cancer was found because doctor did the lifetime risk assessment test': Olivia Munn says mammogram couldn't detect Stage 1 breast cancer

Indian Express12 hours ago

When Hollywood actor Olivia Munn shared her breast cancer journey, it was a wake-up call for millions of women who rely on routine screenings like mammograms to feel safe.
Speaking in a deeply personal interview, Munn revealed that despite having a 'clear mammogram, clear ultrasound, and clear genetic testing', she was diagnosed with multifocal, multi-quadrant, bilateral stage one breast cancer.
'There's this one video I had of me and him (son), and I was laughing and we're playing, and I had had a clear mammogram just around that same time,' Munn said, reflecting on a poignant moment with her son.
So, how was her cancer detected? Through a lifetime risk assessment test—a simple, free online tool known as the Tyrer-Cuzick (or 'Tyreric') model, which evaluates breast cancer risk based on personal and family history.
'And the way that my cancer was found was because my doctor did the lifetime risk assessment test,' Munn explained. 'My doctor took it and she said, 'Your score is 37.3%. Anything above 20% is considered high risk.' She sent me to get an MRI. And after that, I was diagnosed.'
A post shared by The Female Quotient® (@femalequotient)
To better understand how such a life-threatening condition could be missed despite all standard tests being normal, we spoke with Dr Mandeep Singh Malhotra, Director of Surgical Oncology at the CK Birla Hospital, Delhi.
'Mammograms, while widely used for breast cancer screening, are not 100% foolproof,' Dr Malhotra explained. 'Their sensitivity is especially reduced in women with dense breast tissue, which is common among younger women and around 30% of Indian women over 45.'
Dense breast tissue can obscure potential tumours on a mammogram, making cancer more challenging to detect. This is why mammography is usually recommended after 45, when breast density typically decreases. Still, even post-45, mammograms are not infallible.
Dr Malhotra suggests a layered approach. While mammograms are a valuable first step, risk assessment tools like Munn's can flag high-risk individuals who might benefit from MRI scans, which offer higher sensitivity—especially useful when mammograms fail.
'This test has been around for a very long time. It's just not something people have heard about a lot,' Munn said. 'If every woman just knew that they could have their own score and take it to their doctor, it could change their life.'
Self-awareness is also vital. Self-breast examinations starting from age 25–30 and regular clinical breast exams every 6–12 months can help detect early signs, especially for women with dense breasts or those under 45.
Other future-forward methods, like liquid biopsy, which detects cancer via blood tests, are still under development but may become game-changers.
As Dr Malhotra reiterates, 'Until we have perfect tools, the best approach is personal vigilance, risk-based screening, and regular check-ups.'
So, if you've had a 'clear' mammogram, don't stop there—know your risk, ask questions, and take charge of your health. Because, as Olivia herself put it: 'I was doing everything I thought I had to do to take care of myself… and I still had cancer.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Weight-loss drug Wegovy starts at ₹17,345 in India
Weight-loss drug Wegovy starts at ₹17,345 in India

Time of India

timean hour ago

  • Time of India

Weight-loss drug Wegovy starts at ₹17,345 in India

Mumbai: Wegovy (semaglutide), the popular weight-loss drug from Danish drug maker Novo Nordisk , is priced between '17,345 and '26,015 across dosages in India. The company announced at its launch that the easy-to-administer once-a-weekly pen-filled injectable will have the advantage of convenient dosing. The drug will be available in five dosing strengths (0.25, 0.5, 1, 1.7 and 2.4 mg) and will be prescribed for long-term chronic weight management and reduction in risk of major adverse cardiovascular events (MACE). Vikrant Shrotriya, MD, Novo Nordisk India, said obesity is a chronic disease and a national epidemic. "Wegovy is a transformative therapeutic solution with the convenience of a world-class, state-of-the-art pen device," he noted. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Нов таблет с Android Pro 14 Murreice Купете сега Undo Ambrish Mithal, chairman and head, endocrinology and diabetes, Max Healthcare , said although the price of Wegovy is not within the reach of the Indian masses, the potential for the drug is huge. Live Events Over time, he said, the cardiovascular benefit of Wegovy 2.4 mg is an important addition to the weight loss benefits. It is clinically proven to reduce cardiac events by 20%, both in people suffering from overweight/obesity with pre-existing heart disease. The drug can be prescribed for patients with BMI over 30 and those with BMI above 27 and pre-existing co-morbidities. Bariatric surgeon Mufazzal Lakdawala told ET that weight-loss drugs are proving to be the game-changers and they have just unlocked the potential for obese patients. He said the new age weight loss drugs could potentially complement bariatric surgery for patients beyond BMI of 45-50 as a weight-loss option. Compared to Wegovy, Mounjaro's 2.5 mg and 5 mg vials, which are also given on a weekly basis, are priced at '14,000 to '17,500 for a month's dose.

Novo Nordisk's Wegovy debuts in India: How it works, who it's for, and how much it costs
Novo Nordisk's Wegovy debuts in India: How it works, who it's for, and how much it costs

Time of India

time2 hours ago

  • Time of India

Novo Nordisk's Wegovy debuts in India: How it works, who it's for, and how much it costs

Source: iStock In a major development for India's fast-growing anti-obesity drug market, Novo Nordisk on Tuesday officially launched Wegovy, its highly anticipated weight-loss medication, marking a direct challenge to Eli Lilly's already available Mounjaro. Wegovy will be rolled out as a once-weekly injectable, delivered via a FlexTouch pen-like device—a user-friendly, self-administered format that eliminates the need for vials or syringes. The drug is expected to be available in Indian pharmacies by the end of June 2025, according to Vikrant Shrotriya, Managing Director of Novo Nordisk India. A market ripe for disruption Novo Nordisk is betting big on India, where nearly 254 million people live with generalized obesity and 351 million with abdominal obesity. The Danish pharma giant sees India as a key market for future sales, aiming to capture a large share of the country's ₹576 crore anti-obesity drug market, which has quadrupled from ₹133 crore in 2021, according to PharmaTrac. 'Obesity is not just a personal health concern — it is a chronic disease and a national epidemic that India cannot afford to ignore,' said Shrotriya. 'We are bringing Wegovy with the convenience of a world-class, state-of-the-art pen device, and an India-specific price.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Source: iStock How Wegovy works: Science behind the shot Wegovy contains semaglutide, a GLP-1 receptor agonist, which mimics a natural hormone responsible for regulating blood sugar, reducing appetite, delaying gastric emptying, and improving satiety. While related drugs like Ozempic are used primarily for type 2 diabetes, Wegovy is specifically approved for chronic weight management in cases of morbid obesity. The FlexTouch device allows patients to dial in their weekly dose, with four needles included in each monthly pack. The drug works on key centers of the brain that regulate hunger and food cravings, promoting weight loss while offering additional metabolic benefits. According to diabetologist Dr. V. Mohan, 'Clinical data on semaglutide demonstrates not just weight loss but also considerable improvement in cardiovascular risk factors and inflammatory markers. For Indians, where diabetes and heart disease are on the rise, access to such evidence-based therapy offers holistic benefits.' India-specific pricing for Wegovy: Full dose list With a pricing strategy tailored for the Indian market, Novo Nordisk is offering the same cost for the initial three dosing strengths: Dose Monthly Price (₹) Per Dose (₹) 0.25 mg ₹17,345 ₹4,366 0.5 mg ₹17,345 ₹4,366 1 mg ₹17,345 ₹4,366 1.75 mg ₹24,280 ₹6,070 2.4 mg ₹26,015 ₹6,503 By comparison, Mounjaro, which contains the dual-action compound tirzepatide, is priced more competitively: Source: iStock Mounjaro Dose Monthly Price (₹) 2.5 mg ₹14,000 5 mg ₹17,500 Results comparable to bariatric surgery — but with caveats Wegovy has demonstrated remarkable outcomes in clinical studies, positioning it as a breakthrough in the treatment of obesity and related conditions. Patients using the drug experienced an average weight loss of nearly 15%, with one in three shedding as much as 20% of their body weight. Beyond weight loss, Wegovy also significantly reduces the risk of major cardiovascular events such as heart attacks and strokes. The drug also had notable benefits for liver health and showed improvement in liver fibrosis. However, the benefits of Wegovy are tied closely to continued use. Discontinuation often results in weight regain, and medical experts have raised concerns about potential muscle mass loss over time, underscoring the need for long-term management and monitoring. Wegovy vs. Mounjaro: Key differences Aspect Wegovy (Semaglutide) Mounjaro (Tirzepatide) Mechanism GLP-1 receptor agonist Dual GIP and GLP-1 receptor agonist Effect Reduces appetite, delays gastric emptying Enhances insulin secretion, appetite suppression Indication Approved for weight loss Approved for diabetes, used off-label for weight loss Dosing Once a week via Flexpen Once a week via single-dose vials Price ₹17,345–₹26,015 per month ₹14,000–₹17,500 per month One step to a healthier you—join Times Health+ Yoga and feel the change

Ways to rice water Using beyond cooking
Ways to rice water Using beyond cooking

Time of India

time3 hours ago

  • Time of India

Ways to rice water Using beyond cooking

Rice water, the starchy liquid left after soaking or boiling rice — is often discarded in kitchens. But this humble byproduct is a treasure trove of nutrients, packed with amino acids, vitamins, and minerals. Tired of too many ads? go ad free now Traditionally used in many Asian cultures for skincare, hair care, and even home remedies, rice water is making a modern comeback. Here are several ways you can use rice water beyond just cooking. As a Natural Hair Rinse Rice water is rich in inositol, a carbohydrate that strengthens hair, reduces friction, and adds shine. Use fermented rice water as a final hair rinse after shampooing. It helps reduce frizz, detangles hair, and may also promote growth. A study published in the International Journal of Cosmetic Science (2010) highlighted how inositol from rice water penetrates hair strands and repairs damage. For Glowing Skin Used as a toner or face mist, rice water can brighten the skin, tighten pores, and soothe inflammation. It contains antioxidants and starches that calm irritated skin and improve elasticity. Regular application can help reduce pigmentation and boost hydration, especially for sensitive or acne-prone skin. Natural Plant Fertilizer Rice water is an excellent natural fertilizer for plants. The leftover starch nourishes soil microbes and encourages root growth. Use diluted, unseasoned rice water to water plants once or twice a week. It's particularly beneficial for leafy greens and potted herbs. Digestive Health In traditional Indian and Asian medicine, rice water is consumed to soothe an upset stomach. It's light, hydrating, and can help manage diarrhea or mild dehydration. Tired of too many ads? go ad free now The starch content helps coat the stomach lining and improve digestion. Simply boil rice in extra water and strain out the liquid for use. Coolant in Summer Rice water is a natural coolant and is traditionally consumed in tropical regions during hot months. Add a pinch of salt and lemon to it for an instant homemade electrolyte drink. It helps prevent heatstroke, especially when consumed during peak summer afternoons. Homemade face packs Rice water can be added to gram flour, sandalwood, or multani mitti (Fuller's earth) to make skin-brightening face packs. It acts as a gentle base that enhances the pack's anti-inflammatory and tightening properties. Regular use can leave the skin smooth and radiant.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store